PCR-DHPLC for Non-Invasive Prenatal Evaluation of the IVS-II-1 (G>A) Mutation in Fetal DNA of β-Thalassemia Major: A Pilot Diagnostic Performance Study
ACTA MEDICA IRANICA · 14.10.2026
DOI: 10.18502/acta.v64i9.22952 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA MEDICA IRANICA, online erschienen am 14.10.2026. Verfasst von Mandana Zafari und 7 weiteren Autor:innen.
Abstract (Originalsprache)
β-thalassemia is one of the most common autosomal recessive single-gene disorders, particularly in high-prevalence regions. This study aimed to explore the feasibility and diagnostic performance of polymerase chain reaction-denaturing high-performance liquid chromatography (PCR-DHPLC) for non-invasive prenatal detection of the IVS-II-1 (G>A) mutation in fetal DNA. Fifty pregnant women at risk of carrying a fetus with β-thalassemia major were enrolled. Cell-free DNA was extracted from maternal plasma and analyzed using high-resolution melting (HRM) real-time PCR, followed by PCR amplification. Amplicons were assessed by electrophoresis, purified using a PCR purification kit, and subsequently analyzed by DHPLC under predefined buffer and temperature conditions to detect the IVS-II-1 (G>A) mutation. DHPLC analysis identified 13 true positive, 11 true negative, 19 false negative, and 7 false positive cases compared with the invasive reference method. The calculated sensitivity and specificity were 40.6% and 61.1%, respectively, indicating limited diagnostic performance in the current setting. PCR-DHPLC does not provide sufficient sensitivity and specificity for reliable non-invasive prenatal detection of the IVS-II-1 (G>A) mutation in β-thalassemia major. Further methodological optimization and extended mutation panels in larger cohorts are necessary to assess its potential for clinical validation.
Zitieren
APA
Zafari, M., Sadeghi, T., Banihashemi, S., Hashemi, A., Bakhtiyari, M., Kowsaryan, M., Gill, P., & Musavi, H. (2026). PCR-DHPLC for Non-Invasive Prenatal Evaluation of the IVS-II-1 (G>A) Mutation in Fetal DNA of β-Thalassemia Major: A Pilot Diagnostic Performance Study. ACTA MEDICA IRANICA. https://doi.org/10.18502/acta.v64i9.22952
Vancouver
Zafari M, Sadeghi T, Banihashemi S, Hashemi A, Bakhtiyari M, Kowsaryan M, et al. PCR-DHPLC for Non-Invasive Prenatal Evaluation of the IVS-II-1 (G>A) Mutation in Fetal DNA of β-Thalassemia Major: A Pilot Diagnostic Performance Study. ACTA MEDICA IRANICA. 2026. doi:10.18502/acta.v64i9.22952
BibTeX
@article{Zafari2026,
author = {Zafari, Mandana and Sadeghi, Taher and Banihashemi, Sara and Hashemi, Amirreza and Bakhtiyari, Maryam and Kowsaryan, Mehrnoush and Gill, Pooria and Musavi, Hadis},
title = {PCR-DHPLC for Non-Invasive Prenatal Evaluation of the IVS-II-1 (G>A) Mutation in Fetal DNA of β-Thalassemia Major: A Pilot Diagnostic Performance Study},
journal = {ACTA MEDICA IRANICA},
year = {2026},
doi = {10.18502/acta.v64i9.22952}
}
EUVIMED